A novel signature of combing cuproptosis- with ferroptosis-related genes for prediction of prognosis, immunologic therapy responses and drug sensitivity in hepatocellular carcinoma

por Zhao, Chuanbing, Zhang, Zhengle, Jing, Tao
Publicado 2022

A Novel Ferroptosis-Related Signature for Prediction of Prognosis, Immune Profiles and Drug Sensitivity in Hepatocellular Carcinoma Patients

por Zhao, Chuanbing, Zhang, Zhengle, Tao, Jing
Publicado 2022

Alterations of oral microbiota are associated with the development and severity of acute pancreatitis

por Liu, Yiting, Liu, Hang, Rong, Yuping, Shi, Qiao, Yang, Qiang, Li, Hanjun, Zhang, Zhengle, Tao, Jing
Publicado 2023

Up‐regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine‐resistant pancreatic cancer cells

por Zhao, Hengqiang, Duan, Qingke, Zhang, Zhengle, Li, Hehe, Wu, Heshui, Shen, Qiang, Wang, Chunyou, Yin, Tao
Publicado 2017

Mechanistic Evaluation and Translational Signature of Gemcitabine-induced Chemoresistance by Quantitative Phosphoproteomics Analysis with iTRAQ Labeling Mass Spectrometry

por Duan, Qingke, Zhao, Hengqiang, Zhang, Zhengle, Li, Hehe, Wu, Heshui, Shen, Qiang, Wang, Chunyou, Yin, Tao
Publicado 2017

Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling

por Zhang, Zhengle, Han, Han, Rong, Yuping, Zhu, Kongfan, Zhu, Zhongchao, Tang, Zhigang, Xiong, Chenglong, Tao, Jing
Publicado 2018

ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer

por Zhao, Hengqiang, Wu, Shihong, Li, Hehe, Duan, Qingke, Zhang, Zhengle, Shen, Qiang, Wang, Chunyou, Yin, Tao
Publicado 2019

Correction: Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells

por Li, Hehe, Zhang, Zhengle, Gao, Chenggang, Wu, Shihong, Duan, Qingke, Wu, Heshui, Wang, Chunyou, Shen, Qiang, Yin, Tao
Publicado 2023

Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells

por Li, Hehe, Zhang, Zhengle, Gao, Chenggang, Wu, Shihong, Duan, Qingke, Wu, Heshui, Wang, Chunyou, Shen, Qiang, Yin, Tao
Publicado 2019

Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine

por Yin, Tao, Zhang, Zhengle, Cao, Bin, Duan, Qingke, Shi, Pengfei, Zhao, Hengqiang, Camara, Soriba Naby, Shen, Qiang, Wang, Chunyou
Publicado 2016